Clinical Trials Browser

Phase 3 × Recurrence × Topotecan × Clear all

NCT00276276 2013-04-15

Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer

Phase 3 Completed

Lung Neoplasms, Recurrence, Small Cell Lung Carcinoma